Cargando…
Preventive Effect of Dipeptidyl Peptidase-4 Inhibitor on Atherosclerosis Is Mainly Attributable to Incretin's Actions in Nondiabetic and Diabetic Apolipoprotein E-Null Mice
AIM: Several recent reports have revealed that dipeptidyl peptidase (DPP)-4 inhibitors have suppressive effects on atherosclerosis in apolipoprotein E-null (Apoe (−/−)) mice. It remains to be seen, however, whether this effect stems from increased levels of the two active incretins, glucagon-like pe...
Autores principales: | Terasaki, Michishige, Nagashima, Masaharu, Nohtomi, Kyoko, Kohashi, Kyoko, Tomoyasu, Masako, Sinmura, Kyoko, Nogi, Yukinori, Katayama, Yuki, Sato, Kengo, Itoh, Fumiko, Watanabe, Takuya, Hirano, Tsutomu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3742603/ https://www.ncbi.nlm.nih.gov/pubmed/23967137 http://dx.doi.org/10.1371/journal.pone.0070933 |
Ejemplares similares
-
Glucose-Dependent Insulinotropic Polypeptide Prevents the Progression of Macrophage-Driven Atherosclerosis in Diabetic Apolipoprotein E-Null Mice
por: Nogi, Yukinori, et al.
Publicado: (2012) -
A Dipeptidyl Peptidase-4 Inhibitor Suppresses Macrophage Foam Cell Formation in Diabetic db/db Mice and Type 2 Diabetes Patients
por: Terasaki, Michishige, et al.
Publicado: (2018) -
Combination Therapy with a Sodium-Glucose Cotransporter 2 Inhibitor and a Dipeptidyl Peptidase-4 Inhibitor Additively Suppresses Macrophage Foam Cell Formation and Atherosclerosis in Diabetic Mice
por: Terasaki, Michishige, et al.
Publicado: (2017) -
Native incretins prevent the development of atherosclerotic lesions in apolipoprotein E knockout mice
por: Nagashima, M., et al.
Publicado: (2011) -
The role of endothelial nitric oxide in the anti-restenotic effects of liraglutide in a mouse model of restenosis
por: Kushima, Hideki, et al.
Publicado: (2017)